Efinaconazole Topical Solution is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream
Tavaborole Topical Solution, 5%, is an oxaborole antifungal.
Subscribe To Our Newsletter & Stay Updated
